- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
Patent holdings for IPC class C12Q 1/6827
Total number of patents in this class: 2102
10-year publication summary
51
|
83
|
91
|
223
|
327
|
335
|
303
|
258
|
261
|
78
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Natera, Inc. | 265 |
51 |
Guardant Health, Inc. | 312 |
40 |
Illumina, Inc. | 2771 |
34 |
Bio-Rad Laboratories, Inc. | 1592 |
33 |
The Chinese University of Hong Kong | 147 |
26 |
The Regents of the University of California | 18943 |
25 |
Regeneron Pharmaceuticals, Inc. | 3650 |
25 |
The Broad Institute, Inc. | 1584 |
24 |
Massachusetts Institute of Technology | 9795 |
23 |
10X Genomics, Inc. | 921 |
23 |
Foundation Medicine, Inc. | 260 |
20 |
Affymetrix, Inc. | 273 |
19 |
President and Fellows of Harvard College | 5792 |
18 |
Children's Medical Center Corporation | 1780 |
18 |
Exact Sciences Corporation | 275 |
18 |
Roche Molecular Systems, Inc. | 878 |
17 |
The Johns Hopkins University | 5377 |
16 |
The Chinese University of Hong Kong | 615 |
16 |
Grail, LLC | 203 |
16 |
F. Hoffmann-La Roche AG | 7958 |
15 |
Other owners | 1625 |